Literature DB >> 11189746

The changing face of AIDS-related opportunism: cryptococcosis in the highly active antiretroviral therapy (HAART) era. Case reports and literature review.

R Manfredi1, F Pieri, S A Pileri, F Chiodo.   

Abstract

Only nine cases of AIDS-related cryptococcosis have been reported until now in patients receiving highly active antiretroviral therapy (HAART), all of them with abnormal clinical features. Two HIV-infected patients who experienced an atypical relapse of cryptococcosis shortly after the start of HAART and despite maintenance antifungal treatment, are described. Six different relapses of cryptococcal meningitis were observed in a 28-month period in a patient who obtained a poor immune recovery after HAART (as shown by a CD4+ lymphocyte count ranging from 78 to 149 cells/microL, opposed to a baseline level of 98 cells/microL). On the other hand, a patient with favorable immunological response to HAART (as expressed by a CD4+ count growing from 7 to 186 cells/microL), experienced isolated multiple indolent cryptococcal abscesses involving head, neck, the anterior thoracic wall, and regional lymph nodes, with repeatedly negative cultures, and diagnosis obtained by both histopathologic study and positive serum antigen assay. Both our case reports are representative of novel correlations between opportunistic pathogens and immune reactivity, descending from the introduction of HAART. The first episode describes an exceedingly elevated number of disease relapses despite HAART and antifungal maintenance treatment, which may descend from an incomplete immune response to antiretroviral therapy, possibly responsible for failure in obtaining eradication of yeasts, but also for lack of disease dissemination (usually leading to a lethal multivisceral involvement in the pre-HAART era). The abnormal disease course and localization of second reported patient well depicts an "immune reconstitution syndrome" probably representing a flare-up of a latent fungal infection, caused by a rapidly effective HAART. In patients treated with HAART, AIDS-related cryptococcosis cannot therefore be ruled out by the absence of neurological involvement, and by persistingly negative cultures.

Entities:  

Mesh:

Year:  1999        PMID: 11189746     DOI: 10.1023/a:1007156027134

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  24 in total

1.  Mediastinal lymphadenitis due to cryptococcal infection in HIV-positive patients on highly active antiretroviral therapy.

Authors:  M Lanzafame; M Trevenzoli; G Carretta; L Lazzarini; S Vento; E Concia
Journal:  Chest       Date:  1999-09       Impact factor: 9.410

Review 2.  New approaches to managing opportunistic infections.

Authors:  J Lundgren; H Masur
Journal:  AIDS       Date:  1999       Impact factor: 4.177

3.  Changes in AIDS-defining illnesses in a London Clinic, 1987-1998.

Authors:  A Mocroft; C A Sabin; M Youle; S Madge; M Tyrer; H Devereux; J Deayton; A Dykhoff; M C Lipman; A N Phillips; M A Johnson
Journal:  J Acquir Immune Defic Syndr       Date:  1999-08-15       Impact factor: 3.731

4.  Decline in the rate of specific opportunistic infections at San Francisco General Hospital, 1994-1997.

Authors:  C D Holtzer; M A Jacobson; W K Hadley; L Huang; H D Stanley; R Montanti; M K Wong; J D Stansell
Journal:  AIDS       Date:  1998-10-01       Impact factor: 4.177

5.  The incidence and spectrum of AIDS-defining illnesses in persons treated with antiretroviral drugs.

Authors:  D M Forrest; E Seminari; R S Hogg; B Yip; J Raboud; L Lawson; P Phillips; M T Schechter; M V O'Shaughnessy; J S Montaner
Journal:  Clin Infect Dis       Date:  1998-12       Impact factor: 9.079

6.  Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.

Authors:  M A Jacobson; M Zegans; P R Pavan; J J O'Donnell; F Sattler; N Rao; S Owens; R Pollard
Journal:  Lancet       Date:  1997-05-17       Impact factor: 79.321

7.  Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation.

Authors:  N G Pakker; D W Notermans; R J de Boer; M T Roos; F de Wolf; A Hill; J M Leonard; S A Danner; F Miedema; P T Schellekens
Journal:  Nat Med       Date:  1998-02       Impact factor: 53.440

8.  Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy. INCAS Study Group.

Authors:  N G Pakker; E D Kroon; M T Roos; S A Otto; D Hall; F W Wit; D Hamann; M E van der Ende; F A Claessen; R H Kauffmann; P P Koopmans; F P Kroon; C H ten Napel; H G Sprenger; H M Weigel; J S Montaner; J M Lange; P Reiss; P T Schellekens; F Miedema
Journal:  AIDS       Date:  1999-02-04       Impact factor: 4.177

Review 9.  Restoration of the immune system with anti-retroviral therapy.

Authors:  B Autran; G Carcelaint; T S Li; G Gorochov; C Blanc; M Renaud; M Durali; D Mathez; V Calvez; J Leibowitch; C Katlama; P Debré
Journal:  Immunol Lett       Date:  1999-03       Impact factor: 3.685

10.  Opportunistic infections occurring during highly active antiretroviral treatment.

Authors:  C Michelet; C Arvieux; C François; J M Besnier; J P Rogez; J P Breux; F Souala; C Allavena; F Raffi; M Garre; F Cartier
Journal:  AIDS       Date:  1998-10-01       Impact factor: 4.177

View more
  11 in total

Review 1.  Management of the immune reconstitution inflammatory syndrome.

Authors:  Graeme Meintjes; James Scriven; Suzaan Marais
Journal:  Curr HIV/AIDS Rep       Date:  2012-09       Impact factor: 5.071

2.  Paradoxical cryptococcal immune reconstitution inflammatory syndrome in advanced chronic kidney disease.

Authors:  Chih-Chin Kao; Vin-Cent Wu; Hsin-Yun Sun; Che-Hsiung Wu
Journal:  Int Urol Nephrol       Date:  2012-05-25       Impact factor: 2.370

Review 3.  HIV disease and advanced age: an increasing therapeutic challenge.

Authors:  Roberto Manfredi
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

4.  Illness of Immune Reconstitution: Recognition and Management.

Authors:  Edward M Gardner; Elizabeth Connick
Journal:  Curr Infect Dis Rep       Date:  2004-12       Impact factor: 3.725

5.  Voriconazole proves effective in long-term treatment of a cerebral cryptococcoma in a chronic nephropathic HIV-negative patient, after fluconazole failure.

Authors:  S Sabbatani; R Manfredi; M Pavoni; A Consales; F Chiodo
Journal:  Mycopathologia       Date:  2004-08       Impact factor: 2.574

6.  Rapid development of IRIS in the form of cryptococcal meningitis after beginning ART.

Authors:  Abida Malik; Parvez A Khan; Fatima Shujatullah; Nazish Fatima; M Shameem; Azfar Siddiqui
Journal:  Med Mycol Case Rep       Date:  2012-08-10

7.  A fatal case of AIDS-defining meningoencephalitis by C. neoformans, sensitive to antifungal therapy.

Authors:  S Mohammad-Khani; B Otremba; R Klein; H H Capelle; F Logemann; F C Bange; R E Schmidt; M Stoll
Journal:  Eur J Med Res       Date:  2010-11-25       Impact factor: 2.175

Review 8.  New Insights into HIV/AIDS-Associated Cryptococcosis.

Authors:  Spinello Antinori
Journal:  ISRN AIDS       Date:  2013-02-25

9.  Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions.

Authors:  Lewis J Haddow; Robert Colebunders; Graeme Meintjes; Stephen D Lawn; Julian H Elliott; Yukari C Manabe; Paul R Bohjanen; Somnuek Sungkanuparph; Philippa J Easterbrook; Martyn A French; David R Boulware
Journal:  Lancet Infect Dis       Date:  2010-11       Impact factor: 25.071

Review 10.  Immune reconstitution inflammatory syndrome in HIV-infected patients receiving antiretroviral therapy : pathogenesis, clinical manifestations and management.

Authors:  Devesh J Dhasmana; Keertan Dheda; Pernille Ravn; Robert J Wilkinson; Graeme Meintjes
Journal:  Drugs       Date:  2008       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.